Meena Rajesh, Hemal Alok, Arora Shilpa Khanna
Department of Pediatrics, Post Graduate Institute of Medical Education & Research and Dr. Ram Manohar Lohia Hospital, Baba Kharag Singh Marg, New Delhi 110001, India.
AIDS Res Treat. 2018 Oct 24;2018:2840467. doi: 10.1155/2018/2840467. eCollection 2018.
With improving standards of care of children living with HIV (CLHIV), pediatric HIV related mortality rates are declining. New challenges like HIV status disclosure are emerging which need to be addressed to ensure their smooth transition into adulthood. Poor disease disclosure rates are observed in CLHIV globally.
This study was done to assess the prevalence of HIV disclosure in North Indian CLHIV, know the perceptions of caregivers regarding disclosure, and evaluate the impact of disclosure on CLHIV.
It was a questionnaire based cross-sectional study carried out amongst 144 caregivers of CLHIV aged 6-16 years attending the pediatric HIV clinic of a tertiary care teaching hospital.
Though the majority (93.8%) caregivers felt that it is important to disclose but only 33% of the children were actually disclosed. Eighty five percent felt that disclosure must be done by one of the family members and correspondingly 73% of the disclosed children were actually disclosed by their parents. Forty seven percent believed that the most appropriate age for disclosure is 10-12 years. The mean age at which disclosure was actually done was 11.06 ± 1.62 years. Comparison of the disclosed and undisclosed CLHIV revealed that the disclosed group had significantly higher age, longer duration of taking ART, and higher proportion of paternal orphans. Age of the CLHIV was the only significant factor for disclosure. Several reasons were cited by the caregivers for nondisclosure. The caregivers observed improved drug adherence in 47.9% of the children following disclosure.
There is a need to develop region specific pediatric HIV disclosure guidelines keeping in mind the caregivers' perceptions. The guidelines must be age appropriate, systematic, and socioculturally acceptable. The most suitable age for disclosure appears to be 10-12 years. Involvement of caregivers and health care providers in the process is a must.
随着感染艾滋病毒儿童(CLHIV)护理标准的提高,儿科艾滋病毒相关死亡率正在下降。诸如披露艾滋病毒感染状况等新挑战正在出现,需要加以应对,以确保他们顺利过渡到成年期。全球范围内,CLHIV的疾病披露率较低。
本研究旨在评估印度北部CLHIV中艾滋病毒披露的患病率,了解护理人员对披露的看法,并评估披露对CLHIV的影响。
这是一项基于问卷调查的横断面研究,对象是在一家三级护理教学医院的儿科艾滋病毒诊所就诊的144名6至16岁CLHIV的护理人员。
尽管大多数(93.8%)护理人员认为披露很重要,但实际上只有33%的儿童被告知。85%的人认为必须由家庭成员之一进行披露,相应地,73%的已披露儿童实际上是由他们的父母披露的。47%的人认为最适合披露的年龄是10至12岁。实际披露的平均年龄为11.06±1.62岁。对已披露和未披露的CLHIV进行比较发现,已披露组的年龄显著更大,接受抗逆转录病毒治疗的时间更长,且父亲为孤儿的比例更高。CLHIV的年龄是披露的唯一重要因素。护理人员列举了一些不披露的原因。护理人员观察到,47.9%的儿童在披露后药物依从性有所改善。
有必要制定针对特定地区的儿科艾滋病毒披露指南,同时考虑护理人员的看法。这些指南必须适合年龄,系统且在社会文化上可接受。最适合披露的年龄似乎是10至12岁。护理人员和医疗保健提供者必须参与这一过程。